Recombinant vaccines are more effective than conventional vaccines. They have several advantages: they are reliable and safer since only a single protein is used rather than the whole organism; this also reduces the risk of illness. Recombinant technology allows scientists to control the type of vector used and choose specific antigens. While only one recombinant vaccine has been approved by the FDA so far, the technology produces a strong protective immune response similar to a natural infection and may be less expensive to produce in the future. However, developing recombinant vaccines is currently very expensive and some ethical concerns remain regarding the use of human subjects in testing.